Evaluation of a Bispecific Antibody Targeting NK Cells for the Elimination of HIV Reservoirs
Background: ‘Shock and kill’ strategies for HIV cure involve reactivating latent virus (i.e. using latency reversal agents), followed by immune-mediated clearance. HIV impairs NK function, hampering their ability to eliminate infected cells, highlighting the need for immunotherapies to enhance NK cytolytic activity against HIV. Methods: We designed a tetravalent bispecific antibody (Bi-Ab32/16), which targets the…